Effect of Cold Air Cooling on the Incidence of Post Inflammatory Hyperpigmentation Following Laser Treatment
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00287001 |
Recruitment Status :
Completed
First Posted : February 6, 2006
Last Update Posted : May 22, 2008
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Nevus Hyperpigmentation | Device: Cold air cooling | Not Applicable |
- 70% incidence of post inflammatory hyperpigmentation has been reported following a Q-switched nd:YAG laser treatment of acquired bilateral nevus of Ota-like macules.
- We assumed that epidermal cooling may minimize the non-specific injury to the epidermis caused during laser irradiation, leading to the decreased incidence of post inflammatory hyperpigmentation.
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 20 participants |
Allocation: | Non-Randomized |
Intervention Model: | Single Group Assignment |
Masking: | Double (Participant, Outcomes Assessor) |
Official Title: | Effect of Cold Air Cooling on the Incidence of Post Inflammatory Hyperpigmentation Following a Q-Switched Nd:YAG Laser Treatment of Acquired Bilateral Nevus of Ota-Like Macules |
Study Start Date : | December 2005 |
Actual Primary Completion Date : | April 2006 |
Actual Study Completion Date : | April 2006 |

Arm | Intervention/treatment |
---|---|
1
1= cool air cooling
|
Device: Cold air cooling |
- Incidence of post inflammatory hyperpigmentation [ Time Frame: 2 weeks ]
- Side effects of cold air cooling and clearing rate of pigmented lesion [ Time Frame: 12 weeks ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 60 Years (Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Subjects with acquired bilateral nevus of Ota-like macules.
- At least 18 years old
- No previous treatment on the condition for a minimum period of 1 month.
Exclusion Criteria:
- Subjects diagnosed of scleroderma, connective tissue disorders, hematologic disorders, hepatitis, infection, or uncontrolled DM
- History of keloid and/or hypertrophic scar.
- Currently on anti-coagulant

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00287001
Thailand | |
Department of Dermatology, Siriraj Hospital, Mahidol University | |
Bangkok, Thailand, 10700 |
Principal Investigator: | Woraphong - Manuskiatti, M.D. | Mahidol University |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | Worapong Manuskiatti, Mahidol University |
ClinicalTrials.gov Identifier: | NCT00287001 |
Other Study ID Numbers: |
185/2005 |
First Posted: | February 6, 2006 Key Record Dates |
Last Update Posted: | May 22, 2008 |
Last Verified: | February 2007 |
Acquired bilateral nevus of Ota-like macules Postinflammatory hyperpigmentation Cold air cooling |
Hyperpigmentation Pigmentation Disorders Skin Diseases |